CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...